During the past decade, Healthy Heart Cardiology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Healthy Heart Cardiology" #1 sponsor was "Amgen" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "NewAmsterdam Pharma" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Healthy Heart Cardiology" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Syntactx" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Healthy Heart Cardiology" are "Atherosclerotic Cardiovascular Disease" (3 trials), "Cardiovascular Disease" (2 trials), "Chronic Kidney Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Genetics of Drug Metabolism" (1 trials). Many other conditions were trialed in "Healthy Heart Cardiology" in a lesser frequency.

Most popular intervention types in "Healthy Heart Cardiology" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "Empagliflozin" (1 trials), "Evolocumab" (1 trials) and "Inclisiran sodium 300 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Healthy Heart Cardiology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Healthy Heart Cardiology". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Healthy Heart Cardiology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Healthy Heart Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".